PT - JOURNAL ARTICLE AU - Jamie Shutler AU - Krzysztof Zaraska AU - Tom Holding AU - Monika Machnik AU - Kiranmai Uppuluri AU - Ian Ashton AU - Łukasz Migdał AU - Ravinder Dahiya TI - Risk of SARS-CoV-2 infection from contaminated water systems AID - 10.1101/2020.06.17.20133504 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.17.20133504 4099 - http://medrxiv.org/content/early/2020/06/20/2020.06.17.20133504.short 4100 - http://medrxiv.org/content/early/2020/06/20/2020.06.17.20133504.full AB - Following the outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in China, airborne water droplets (aerosols) have been identified as the main transmission route, although other transmission routes are likely to exist. We quantify SARS-CoV-2 virus survivability within water and the risk of infection posed by faecal contaminated water within 39 countries. We identify that the virus can remain stable within water for up to 25 days, and country specific relative risk of infection posed by faecal contaminated water is related to the environment. Faecal contaminated rivers, waterways and water systems within countries with high infection rates can provide infectious doses >100 copies within 100 ml of water. The implications for freshwater systems, the coastal marine environment and virus resurgence are discussed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJDS, KZ and RD were partially supported by the European Union Marie Curie Innovative Training Network AquaSense (grant H2020-MSCA-ITN-2018-813680). RD was partially supported through Engineering and Physical Science Research Council (EPSRC) Engineering Fellowship for Growth (grant EP/R029644/1). JDS and TH were partially supported by the European Space Agency project OceanSODA (grant 4000125955/18/I-BG).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:ethics approval/exemption was given by the university of exeter (as the manuscript analyses open source datasets at the scale of countries and globally).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the input data are open source and freely available on line.